検索
IO Biotech Inc
IOBTウォッチリストに追加
0.048USD
0.0000.00%
終値 07/02, 13:00（ET）15分遅れの株価
366.94K時価総額
損失額直近12ヶ月PER
詳細情報 IO Biotech Inc 企業名
IO Biotech Inc is a clinical-stage biopharmaceutical company developing immune-modulating cancer therapies based on T-win technology platform. The Company’s product candidates are designed to induce the immune system to simultaneously target and disrupt multiple pathways that regulate tumor-induced immunosuppression. IO Biotech’s lead product candidate, IO102-IO103, is designed to target the immunosuppressive mechanisms mediated by key immunosuppressive proteins such as IDO and PD-L1. The Company develops a pipeline of product candidates that leverage its T-win technology platform to address targets within the TME. The Company is spin-off of National Cancer for Center Immune Therapy at Herlev University Hospital in Denmark.
IO Biotech Incの企業情報
企業コードIOBT
会社名IO Biotech Inc
上場日Nov 05, 2021
最高経営責任者「CEO」Zocca (Mai-Britt)
従業員数80
証券種類Ordinary Share
決算期末Nov 05
本社所在地Ole Maaloes Veh 3
都市COPENHAGEN
証券取引所NASDAQ OMX - NASDAQ BASIC
国Denmark
郵便番号2200
電話番号4570702980
ウェブサイトhttps://www.iobiotech.com/
企業コードIOBT
上場日Nov 05, 2021
最高経営責任者「CEO」Zocca (Mai-Britt)
IO Biotech Incの経営陣
会社名
会社名/ポジション
ポジション
株式保有
変動額
Dr. Mai-Britt Zocca, Ph.D.
Dr. Mai-Britt Zocca, Ph.D.
President, Chief Executive Officer, Founder, Director
President, Chief Executive Officer, Founder, Director
76.47K
--
Mr. Devin Whittemore Smith
Mr. Devin Whittemore Smith
General Counsel, Company Secretary
General Counsel, Company Secretary
16.93K
+70.87%
Ms. Heidi Hunter
Ms. Heidi Hunter
Independent Director
Independent Director
15.00K
--
Dr. Peter Hirth, Ph.D.
Dr. Peter Hirth, Ph.D.
Chairman of the Board
Chairman of the Board
--
--
Dr. Christian E. Elling, Ph.D.
Dr. Christian E. Elling, Ph.D.
Independent Director
Independent Director
--
--
Ms. Kathleen Sereda Glaub
Ms. Kathleen Sereda Glaub
Independent Director
Independent Director
--
--
Mr. David V. Smith
Mr. David V. Smith
Independent Director
Independent Director
--
--
Mr. Brian Burkavage
Mr. Brian Burkavage
Senior Vice President, Chief Accounting Officer
Senior Vice President, Chief Accounting Officer
--
--
Ms. Amy B. Sullivan
Ms. Amy B. Sullivan
Chief Financial Officer, Principal Accounting Officer
Chief Financial Officer, Principal Accounting Officer
--
--
Dr. Qasim Ahmad, M.D.
Dr. Qasim Ahmad, M.D.
Chief Medical Officer
Chief Medical Officer
--
--
詳細を見る
会社名
会社名/ポジション
ポジション
株式保有
変動額
Dr. Mai-Britt Zocca, Ph.D.
Dr. Mai-Britt Zocca, Ph.D.
President, Chief Executive Officer, Founder, Director
President, Chief Executive Officer, Founder, Director
76.47K
--
Mr. Devin Whittemore Smith
Mr. Devin Whittemore Smith
General Counsel, Company Secretary
General Counsel, Company Secretary
16.93K
+70.87%
Ms. Heidi Hunter
Ms. Heidi Hunter
Independent Director
Independent Director
15.00K
--
Dr. Peter Hirth, Ph.D.
Dr. Peter Hirth, Ph.D.
Chairman of the Board
Chairman of the Board
--
--
Dr. Christian E. Elling, Ph.D.
Dr. Christian E. Elling, Ph.D.
Independent Director
Independent Director
--
--
Ms. Kathleen Sereda Glaub
Ms. Kathleen Sereda Glaub
Independent Director
Independent Director
--
--
よくある質問
IO Biotech Incの上位5名の株主は誰ですか？
IO Biotech Incの上位5名の株主は以下のとおりです。Dr. Mai-Britt Zocca, Ph.D.
IO Biotech Inc（IOBT）の株式を保有している機関の数はいくつですか？
2026Q1時点で、IO Biotech Incの株式を保有している機関は56社あり、保有株式の総市場価値は約33.96Mで、全体の47.71%を占めています。2025Q4と比較して、機関の持ち株は-19145442.00増加しています。